BridgeMD
New treatment option for Acute Pathology of the Locomotor System
Official title Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.
ClinicalTrials.gov ID: NCT05905146
What this study is testing
- What it's testing
- The aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependence compared to a management according to the usual modalities in the rheumatology services concerned.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient hospitalized in the rheumatology department
- Patient with acute pain in the context of a non-cancerous, non-traumatic, high-energy musculoskeletal pathology
- Patient for whom a prescription of strong opioid derivatives is initiated in rheumatology or patient for whom a prescription of strong opioid...
You likely can't join if
- Patient with cancer or fibromyalgia already diagnosed at inclusion
- Patient with poor French language skills
- Taking a strong opioid treatment for more than 30 consecutive days prior to inclusion
- Person judged by the prescriber or pharmacist as not autonomous for the management of strong opioid treatment
- Patient already included in the study
The study team makes the final eligibility decision.
Where it's taking place
- Lille, France
- Nîmes, France
- Rouen, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, France; Nîmes, France; Rouen, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.